Logo image of SPCB

SUPERCOM LTD (SPCB) Stock Fundamental Analysis

NASDAQ:SPCB - Nasdaq - IL0010830961 - Common Stock - Currency: USD

10.5  -0.68 (-6.08%)

After market: 10.53 +0.03 (+0.29%)

Fundamental Rating

4

Overall SPCB gets a fundamental rating of 4 out of 10. We evaluated SPCB against 125 industry peers in the Electronic Equipment, Instruments & Components industry. SPCB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SPCB has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

SPCB had positive earnings in the past year.
In the past 5 years SPCB reported 4 times negative net income.
In the past 5 years SPCB always reported negative operating cash flow.
SPCB Yearly Net Income VS EBIT VS OCF VS FCFSPCB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.04%, SPCB is in line with its industry, outperforming 54.40% of the companies in the same industry.
SPCB has a Return On Equity of 1.90%. This is comparable to the rest of the industry: SPCB outperforms 56.00% of its industry peers.
Industry RankSector Rank
ROA 1.04%
ROE 1.9%
ROIC N/A
ROA(3y)-8.43%
ROA(5y)-13.77%
ROE(3y)-105.34%
ROE(5y)-141.36%
ROIC(3y)N/A
ROIC(5y)N/A
SPCB Yearly ROA, ROE, ROICSPCB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

SPCB's Profit Margin of 2.39% is fine compared to the rest of the industry. SPCB outperforms 64.00% of its industry peers.
SPCB has a better Gross Margin (48.43%) than 84.00% of its industry peers.
In the last couple of years the Gross Margin of SPCB has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 2.39%
GM 48.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.43%
GM growth 5Y4.68%
SPCB Yearly Profit, Operating, Gross MarginsSPCB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

4

2. Health

2.1 Basic Checks

SPCB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SPCB has been increased compared to 1 year ago.
Compared to 5 years ago, SPCB has more shares outstanding
SPCB has a better debt/assets ratio than last year.
SPCB Yearly Shares OutstandingSPCB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
SPCB Yearly Total Debt VS Total AssetsSPCB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

SPCB has an Altman-Z score of -0.17. This is a bad value and indicates that SPCB is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SPCB (-0.17) is worse than 80.00% of its industry peers.
SPCB has a Debt/Equity ratio of 0.71. This is a neutral value indicating SPCB is somewhat dependend on debt financing.
SPCB has a Debt to Equity ratio of 0.71. This is amonst the worse of the industry: SPCB underperforms 84.80% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Altman-Z -0.17
ROIC/WACCN/A
WACC6.84%
SPCB Yearly LT Debt VS Equity VS FCFSPCB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

A Current Ratio of 9.69 indicates that SPCB has no problem at all paying its short term obligations.
With an excellent Current ratio value of 9.69, SPCB belongs to the best of the industry, outperforming 90.40% of the companies in the same industry.
A Quick Ratio of 9.06 indicates that SPCB has no problem at all paying its short term obligations.
The Quick ratio of SPCB (9.06) is better than 92.80% of its industry peers.
Industry RankSector Rank
Current Ratio 9.69
Quick Ratio 9.06
SPCB Yearly Current Assets VS Current LiabilitesSPCB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

5

3. Growth

3.1 Past

SPCB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 103.19%, which is quite impressive.
Looking at the last year, SPCB shows a small growth in Revenue. The Revenue has grown by 4.01% in the last year.
The Revenue has been growing by 10.90% on average over the past years. This is quite good.
EPS 1Y (TTM)103.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.5%
Revenue 1Y (TTM)4.01%
Revenue growth 3Y31.09%
Revenue growth 5Y10.9%
Sales Q2Q%2.89%

3.2 Future

SPCB is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -0.29% yearly.
The Revenue is expected to grow by 12.66% on average over the next years. This is quite good.
EPS Next Y-107.18%
EPS Next 2Y4.15%
EPS Next 3Y-0.29%
EPS Next 5YN/A
Revenue Next Year0.17%
Revenue Next 2Y10.94%
Revenue Next 3Y12.66%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SPCB Yearly Revenue VS EstimatesSPCB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
SPCB Yearly EPS VS EstimatesSPCB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 50 -50 100 150 200

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 7.45, the valuation of SPCB can be described as very cheap.
95.20% of the companies in the same industry are more expensive than SPCB, based on the Price/Earnings ratio.
SPCB's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.60.
With a Price/Forward Earnings ratio of 13.63, SPCB is valued correctly.
83.20% of the companies in the same industry are more expensive than SPCB, based on the Price/Forward Earnings ratio.
SPCB is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.39, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.45
Fwd PE 13.63
SPCB Price Earnings VS Forward Price EarningsSPCB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

SPCB's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.28
SPCB Per share dataSPCB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.15%
EPS Next 3Y-0.29%

More info and screens

0

5. Dividend

5.1 Amount

SPCB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SUPERCOM LTD

NASDAQ:SPCB (6/12/2025, 7:04:27 PM)

After market: 10.53 +0.03 (+0.29%)

10.5

-0.68 (-6.08%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)08-13 2025-08-13
Inst Owners9.63%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap43.05M
Analysts82.5
Price Target14.28 (36%)
Short Float %10.68%
Short Ratio1.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)849.78%
Min EPS beat(2)-130.55%
Max EPS beat(2)1830.1%
EPS beat(4)2
Avg EPS beat(4)442.19%
Min EPS beat(4)-226.87%
Max EPS beat(4)1830.1%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.94%
Min Revenue beat(2)-4.3%
Max Revenue beat(2)-1.59%
Revenue beat(4)1
Avg Revenue beat(4)3.9%
Min Revenue beat(4)-4.3%
Max Revenue beat(4)23.28%
Revenue beat(8)5
Avg Revenue beat(8)18.01%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-22.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-25%
EPS NY rev (3m)-25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-6.87%
Revenue NY rev (3m)-14.36%
Valuation
Industry RankSector Rank
PE 7.45
Fwd PE 13.63
P/S 1.56
P/FCF N/A
P/OCF N/A
P/B 1.24
P/tB 1.95
EV/EBITDA 20.28
EPS(TTM)1.41
EY13.43%
EPS(NY)0.77
Fwd EY7.33%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.74
BVpS8.48
TBVpS5.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.04%
ROE 1.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 2.39%
GM 48.43%
FCFM N/A
ROA(3y)-8.43%
ROA(5y)-13.77%
ROE(3y)-105.34%
ROE(5y)-141.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.43%
GM growth 5Y4.68%
F-ScoreN/A
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF N/A
Debt/EBITDA 9.44
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.69
Quick Ratio 9.06
Altman-Z -0.17
F-ScoreN/A
WACC6.84%
ROIC/WACCN/A
Cap/Depr(3y)97.09%
Cap/Depr(5y)83.67%
Cap/Sales(3y)12.3%
Cap/Sales(5y)12.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)103.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.5%
EPS Next Y-107.18%
EPS Next 2Y4.15%
EPS Next 3Y-0.29%
EPS Next 5YN/A
Revenue 1Y (TTM)4.01%
Revenue growth 3Y31.09%
Revenue growth 5Y10.9%
Sales Q2Q%2.89%
Revenue Next Year0.17%
Revenue Next 2Y10.94%
Revenue Next 3Y12.66%
Revenue Next 5YN/A
EBIT growth 1Y76.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year345.07%
EBIT Next 3Y136.88%
EBIT Next 5YN/A
FCF growth 1Y19.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y45.33%
OCF growth 3YN/A
OCF growth 5YN/A